Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of Huanghou Zhixie Dripping Pills for IBS-D
CTR20262157Phase 2Active
- Sponsor
- 安徽雷允上药业有限公司
- Start
- Jul 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Huanghou Zhixie dripping pills in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by 安徽雷允上药业有限公司. Started Jul 2026; status: active.
02
Drugs
Huanghou Zhixie dripping pills
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20262157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262157.